BIOMAT Database Logo BIOMAT Database Logo

[Oxygen and tolazoline as vasodilators in pulmonary arterial hypertension secondary to high pulmonary blood flow]. 1987

J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández

UI MeSH Term Description Entries
D006976 Hypertension, Pulmonary Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES. Pulmonary Hypertension
D007223 Infant A child between 1 and 23 months of age. Infants
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D008297 Male Males
D010102 Oxygen Inhalation Therapy Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed) Inhalation Therapy, Oxygen,Therapy, Oxygen Inhalation,Inhalation Therapies, Oxygen,Oxygen Inhalation Therapies,Therapies, Oxygen Inhalation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006330 Heart Defects, Congenital Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life. Congenital Heart Disease,Heart Abnormalities,Abnormality, Heart,Congenital Heart Defect,Congenital Heart Defects,Defects, Congenital Heart,Heart Defect, Congenital,Heart, Malformation Of,Congenital Heart Diseases,Defect, Congenital Heart,Disease, Congenital Heart,Heart Abnormality,Heart Disease, Congenital,Malformation Of Heart,Malformation Of Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
Redistribution of pulmonary blood flow secondary to pulmonary arterial hypertension.
January 1980, Investigative radiology,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
Vasodilators ineffective in secondary pulmonary hypertension.
October 1980, The New England journal of medicine,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
Oxygen-sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension.
January 2021, Antioxidants (Basel, Switzerland),
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
[Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
January 1982, Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
Adaptation of fetal pulmonary blood flow to local infusion of tolazoline.
November 1986, Pediatric research,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
Pulmonary Hypertension and Pulmonary Vasodilators.
March 2016, Clinics in perinatology,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
The role of increased pulmonary blood flow in pulmonary arterial hypertension.
September 2005, The European respiratory journal,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
Vasodilators in pulmonary hypertension.
December 1993, Thorax,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
Pulmonary Arterial Hypertension Secondary to Drugs and Toxins.
March 2021, Clinics in chest medicine,
J L Salgado-Escobar, and M Ledesma-Velasco, and J Munayer-Calderón, and D Núñez-Garduño, and M E Salas-López, and L Rodríguez-Hernández
[Pediatric pulmonary hypertension and pulmonary arterial hypertension secondary to congenital heart diseases].
August 2010, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
Copied contents to your clipboard!